All the more reason to push for a license imo. If the tech works, imagine 25% of sales as royalties on 60 B cell products with the licensee paying for trials. While it would certainly take much longer, it would vastly eclipse any figure from a phase 2 buyout.
At the end of the day though none of us really have a clue and it's all speculation on the high side. But it's fun
Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform', page-241
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.001(2.04%) |
Mkt cap ! $371.8M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.1¢ | 4.9¢ | $776.4K | 15.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 6526158 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 1499998 | 1 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |